Hovr stock forecast reveals a price channel forming

Hovr stock forecast reveals a price channel forming between $14.80–$16.00, indicating possible breakout scenarios. Traders using Bollinger Bands note tightening spreads, traditionally preceding large directional moves in growth stocks. Overview: Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States, with a market cap of approximately $118.03 million. This article was originally published by Simply Wall St . For active traders, Hovr stock forecast is shaped by intraday momentum aligning with broader tech ETF flows. 20-day EMA crossover above 50-day EMA suggests short-term bullish phase if volume sustains.